However, it should also be noted that BPC 157 is a peptide derived from human gastric juices
There are many people who are against these drugs because of how they contribute to the idea that we can and should all be thin, she says theres a fear that this will contribute to more eating disorders, and that people will never be able to accept their bodies, theyll always be told: Well, you could be thinner, just use this medicine. For now, what clinicians can do is what most of them are already doing: screening patients for a history of eating disorders before prescribing GLP-1s
So the benefit of the weight loss medication was extra
It covers why semaglutide and tirzepatide work on different timelines, why appetite suppression arrives before weight loss does, why your neighbor lost ten pounds in month one while you lost three, and what the clinical trial data actually says about realistic expectations
[3] [5] Animal studies have shown effects on thyroid C-cells, so patients should report any neck mass, hoarseness, or difficulty swallowing